| 000 | 01624 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515100013.0 | ||
| 264 | 0 | _c20080603 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a1388-9842 | ||
| 024 | 7 |
_a10.1016/j.ejheart.2007.10.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLittlejohn, Mathew D | |
| 245 | 0 | 0 |
_aIle164 variant of beta2-adrenoceptor does not influence outcome in heart failure but may interact with beta blocker treatment. _h[electronic resource] |
| 260 |
_bEuropean journal of heart failure _cJan 2008 |
||
| 300 |
_a55-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadverse effects |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta-2 _xdrug effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPalmer, Barry R | |
| 700 | 1 | _aRichards, A Mark | |
| 700 | 1 | _aFrampton, Chris M | |
| 700 | 1 | _aPilbrow, Anna P | |
| 700 | 1 | _aTroughton, Richard W | |
| 700 | 1 | _aCameron, Vicky A | |
| 700 | 1 | _aKennedy, Martin A | |
| 773 | 0 |
_tEuropean journal of heart failure _gvol. 10 _gno. 1 _gp. 55-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejheart.2007.10.011 _zAvailable from publisher's website |
| 999 |
_c17582229 _d17582229 |
||